abrdn plc - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 144 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
abrdn plc ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q4 2022$402,548
+189.6%
27,236
+74.6%
0.00%
Q3 2022$139,000
+4.5%
15,599
+48.8%
0.00%
Q2 2022$133,000
-53.2%
10,482
+29.7%
0.00%
-100.0%
Q4 2021$284,000
+3.6%
8,084
+7.9%
0.00%0.0%
Q3 2021$274,000
+24.0%
7,489
+32.8%
0.00%
Q2 2021$221,000
-25.8%
5,639
-46.5%
0.00%
-100.0%
Q1 2021$298,000
-27.3%
10,543
-17.8%
0.00%0.0%
Q4 2020$410,000
+9.9%
12,820
+11.0%
0.00%0.0%
Q3 2020$373,000
+2.8%
11,549
-30.0%
0.00%0.0%
Q2 2019$363,00016,5000.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders